Allspring Global Investments Holdings LLC Raises Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Allspring Global Investments Holdings LLC raised its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 30.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,214 shares of the company’s stock after purchasing an additional 1,928 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Privia Health Group were worth $189,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Covestor Ltd lifted its position in Privia Health Group by 8.3% in the third quarter. Covestor Ltd now owns 6,703 shares of the company’s stock valued at $154,000 after buying an additional 514 shares during the last quarter. Yousif Capital Management LLC lifted its holdings in shares of Privia Health Group by 1.1% in the 3rd quarter. Yousif Capital Management LLC now owns 52,065 shares of the company’s stock worth $1,197,000 after acquiring an additional 574 shares during the last quarter. New York State Common Retirement Fund boosted its position in shares of Privia Health Group by 2.7% during the 3rd quarter. New York State Common Retirement Fund now owns 27,966 shares of the company’s stock worth $643,000 after purchasing an additional 737 shares during the period. Glenmede Trust Co. NA increased its holdings in Privia Health Group by 0.9% in the 3rd quarter. Glenmede Trust Co. NA now owns 107,711 shares of the company’s stock valued at $2,477,000 after purchasing an additional 976 shares during the last quarter. Finally, Oregon Public Employees Retirement Fund raised its position in Privia Health Group by 3.8% in the third quarter. Oregon Public Employees Retirement Fund now owns 30,300 shares of the company’s stock valued at $697,000 after purchasing an additional 1,100 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Trading Up 1.5 %

Shares of PRVA stock opened at $18.26 on Friday. The company has a market cap of $2.17 billion, a P/E ratio of 96.11, a PEG ratio of 2.46 and a beta of 0.81. The firm has a fifty day moving average price of $19.81 and a 200 day moving average price of $21.23. Privia Health Group, Inc. has a 12 month low of $17.54 and a 12 month high of $30.15.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02). Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. The business had revenue of $440.80 million for the quarter, compared to analysts’ expectations of $425.81 million. During the same period last year, the firm earned $0.14 earnings per share. The firm’s quarterly revenue was up 21.0% on a year-over-year basis. On average, equities analysts forecast that Privia Health Group, Inc. will post 0.26 EPS for the current year.

Insider Buying and Selling at Privia Health Group

In other Privia Health Group news, CFO David Mountcastle sold 3,933 shares of Privia Health Group stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total transaction of $69,889.41. Following the transaction, the chief financial officer now owns 262,279 shares of the company’s stock, valued at $4,660,697.83. The transaction was disclosed in a filing with the SEC, which is available at this link. 14.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Evercore ISI dropped their price objective on Privia Health Group from $26.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, February 28th. Barclays started coverage on shares of Privia Health Group in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $22.00 price target on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Privia Health Group from $38.00 to $30.00 and set an “overweight” rating for the company in a research note on Wednesday, March 6th. Canaccord Genuity Group cut their target price on shares of Privia Health Group from $41.00 to $37.00 and set a “buy” rating on the stock in a research note on Tuesday, March 19th. Finally, UBS Group decreased their price target on shares of Privia Health Group from $31.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, March 1st. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $27.92.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.